资讯
| 09-18 17:43 | Avantis | 其他 | Biotech. $LLY — orals expanding the market, or trading injectable economics for cash-pay economics? $MRNA — Intismeran turns a per-patient therapy into a real franchise, or the readout bought optionality the balance sheet still has to finance? X 上的 @verantaxyz ↗ |
Avantis标签由程序自动生成，可能有误。